Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Mucolytics in cystic fibrosis
2007
Making sense of complexity in context and implementation: the Context and Implementation of Complex Interventions (CICI) framework
2017
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Quality-of-life outcomes after surgical correction of pectus excavatum: a comparison of the Ravitch and Nuss procedures
2008
Hemoglobin desaturation during sleep and daytime in patients with cystic fibrosis and severe airway obstruction
1992
Escherichia coli 0157:H7: Clinical, Diagnostic, and Epidemiological Aspects of Human Infection
1995
Cardiac ischemia during hemolytic uremic syndrome
2003
Cystic fibrosis
2016 Standout
Cystic fibrosis
2003
Nucleotide signalling during inflammation
2014 StandoutNature
Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)
2014
Managing Cystic Fibrosis
2011
Cystic Fibrosis Pulmonary Guidelines
2007
Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy
2011
Exercised-induced asthma revisited
1993
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Pharmacokinetic aspects of biotechnology products
2004
Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo
2012 Standout
Neutrophil Extracellular Trap (NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired Resistance within the CF Airway, Independent of CFTR
2011
The effect of adenotonsillectomy on serum insulin-like growth factor-I and growth in children with obstructive sleep apnea syndrome
1999
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Five Years of GWAS Discovery
2012 Standout
Antibiotic resistance of bacterial biofilms
2010 Standout
Marfan's syndrome
2005
Effect of aerosolized rhDNase (Pulmozyme®) on pulmonary colonization in patients with cystic fibrosis
2006
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis
2011
Dornase alfa in early cystic fibrosis lung disease
2002
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
2014
Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis
2002
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
2004
Twenty-One Years of Experience With Minimally Invasive Repair of Pectus Excavatum by the Nuss Procedure in 1215 Patients
2010 Standout
Neutrophil extracellular traps in immunity and disease
2017 Standout
A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect
2013
Phase 2 Randomized Safety and Efficacy Trial of Nebulized Denufosol Tetrasodium in Cystic Fibrosis
2007
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Escherichia coli O157:H7–associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers
1994
The Effect of High Doses of Inhaled Salbutamol and Ipratropium Bromide in Patients With Stable Cystic Fibrosis
1993
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
2021 Standout
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Cystic Fibrosis Pulmonary Guidelines
2013
Gut flora in health and disease
2003 Standout
Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study
2007
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Pulmonary Hypertension and Cardiac Function in Adult Cystic Fibrosis
1999
Development of a New Patient-Reported Outcome Measure for Breast Surgery: The BREAST-Q
2009 Standout
Airway Mucus Function and Dysfunction
2010 Standout
Detecting early structural lung damage in cystic fibrosis
2002
Mesoporous Materials for Drug Delivery
2007 Standout
Extracellular DNA traps in inflammation, injury and healing
2019
Practice Parameters for the Indications for Polysomnography and Related Procedures: An Update for 2005
2005 Standout
Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial
2009
Spring Cleaning: Rural Water Impacts, Valuation, and Property Rights Institutions*
2011 StandoutNobel
Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen
1997
Sustained Benefit from Ivacaftor Demonstrated by Combining Clinical Trial and Cystic Fibrosis Patient Registry Data
2015
Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
2013
Risk Factors for Airway Remodeling in Asthma Manifested by a Low Postbronchodilator FEV 1 /Vital Capacity Ratio
2002
Discriminative Capacity of Bronchodilator Response Measured with Three Different Lung Function Techniques in Asthmatic and Healthy Children Aged 2 to 5 Years
2001
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
The expansion of temporary help employment in the US, 1982-1992: a test of alternative economic explanations
1996
An Organization-Level Analysis of Voluntary and Involuntary Turnover
1998
AN ORGANIZATION-LEVEL ANALYSIS OF VOLUNTARY AND INVOLUNTARY TURNOVER.
1998 Standout
WHY PEOPLE STAY: USING JOB EMBEDDEDNESS TO PREDICT VOLUNTARY TURNOVER.
2001 Standout
New Market Power Models and Sex Differences in Pay
2010
Reasons for Hiring Part‐Time Workers
1992
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
2021 StandoutNobel
A gradient of childhood self-control predicts health, wealth, and public safety
2011 Standout
Employee Voice, Human Resource Practices, and Quit Rates: Evidence from the Telecommunications Industry
2002
Factors affecting farmers’ adoption of integrated pest management in Serbia: An application of the theory of planned behavior
2019 Standout
Willingness to pay for environmental goods in Norway: A contingent valuation study with real payment
1992
The Impact of High-Performance Human Resource Practices on Employees’ Attitudes and Behaviors
2010 Standout
The cognitive map as a hippocampus
1979 StandoutNobel
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
A Grand Gender Convergence: Its Last Chapter
2014 StandoutNobel
Contingent Valuation: Is Some Number Better than No Number?
1994 StandoutNobel
The Gender Wage Gap: Extent, Trends, and Explanations
2017 Standout
Precarious Work, Insecure Workers: Employment Relations in Transition
2009 Standout
MANAGING CUSTOMER SERVICES: HUMAN RESOURCE PRACTICES, QUIT RATES, AND SALES GROWTH.
2002
Is Part-Time Employment Beneficial for Firm Productivity?
2013
Nonstandard Employment Relations: Part-time, Temporary and Contract Work
2000 Standout
Demand for Part-time Workers in the U.S. Economy: Why is the Distribution across Industries Uneven?
1998
Pathophysiology of Sleep Apnea
2010 Standout
Nebulised hypertonic saline for cystic fibrosis
2018
Angle between choice alleys as a critical factor in spontaneous alternation
1974
Contingent Valuation and Revealed Preference Methodologies: Comparing the Estimates for Quasi-Public Goods
1995
How Does Human Resource Management Influence Organizational Outcomes? A Meta-analytic Investigation of Mediating Mechanisms
2012 Standout
Why Do Part-Time Workers Earn Less? The Role of Worker and Job Skills
2005
HOW MUCH DO HIGH‐PERFORMANCE WORK PRACTICES MATTER? A META‐ANALYSIS OF THEIR EFFECTS ON ORGANIZATIONAL PERFORMANCE
2006 Standout
Précis of O'Keefe & Nadel'sThe hippocampus as a cognitive map
1979 StandoutNobel
Innovation adoption in agriculture : innovators, early adopters and laggards
2003
Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections
1998 Standout
HIGH-INVOLVEMENT WORK PRACTICES, TURNOVER, AND PRODUCTIVITY: EVIDENCE FROM NEW ZEALAND.
2001 Standout
High-Performance Human Resource Practices, Citizenship Behavior, and Organizational Performance: A Relational Perspective
2007 Standout
Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6
2002
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Works of Mark Montgomery being referenced
Long term cardiopulmonary effects of closed repair of pectus excavatum
2007
Guidance for considering ethical, legal, and social issues in health technology assessment: Application to genetic screening
2008
Newborn screening for cystic fibrosis in Alberta: Two years of experience
2010
Relationship between response to inhaled salbutamol and methacholine bronchial provocation in children with suspected asthma
1991
Home measurement of oxygen saturation during sleep in patients with cystic fibrosis
1989
A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities
2001
Midterm evaluation of cardiopulmonary effects of closed repair for pectus excavatum
2005
Effect of terfenadine on the response to exercise and cold air in asthma
1988
A nested logit model of the choice of a graduate business school
2002
The Effect of Employee Benefits on the Demand for Part-Time Workers
1993
Causes of death in hemolytic uremic syndrome.
1991
On the Determinants of Employer Demand for Part-Time Workers
1988
Reliability and predictive validity of contingent values: Does the nature of the good matter?
1990
Compensation Structure and Establishment Quit and Fire Rates
1994
Dornase alfa for cystic fibrosis
2018
Effects of body weight loss on position and brightness discrimination tasks
1970
Dornase alfa for cystic fibrosis
2016
ARE PART‐TIME WOMEN PAID LESS? A MODEL WITH FIRM‐SPECIFIC EFFECTS
1995